TerminatedPhase 1NCT01814059
Sirolimus for Eosinophil-Associated Gastrointestinal Disorders
Studying Eosinophilic gastroenteritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Calman P Prussin, M.D., M.DNational Institute of Allergy and Infectious Diseases (NIAID)
- Intervention
- sirolimus(drug)
- Enrollment
- 4 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2013 – 2015
Study locations (1)
- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01814059 on ClinicalTrials.govOther trials for Eosinophilic gastroenteritis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07506746PRospective Registry of Esophageal MotilityIRCCS San Raffaele
- ACTIVE NOT RECRUITINGPHASE2NCT05831176A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May HaveRegeneron Pharmaceuticals